Brazil Nuclear Imaging Market Size and Share

Market Snapshot
Image © Mordor Intelligence. Reuse requires attribution under CC BY 4.0.
View Global Report

Brazil Nuclear Imaging Market Analysis by Mordor Intelligence

The Brazil nuclear imaging market size stands at USD 241.27 billion in 2025 and is forecast to expand to USD 335.14 billion by 2030 at a 6.79% CAGR. Accelerated demand for precision diagnostics in oncology and cardiology, rapid uptake of digital PET/CT and full-ring CZT SPECT platforms, and federal investment in domestic molybdenum-99 production collectively underpin this trajectory. Private insurers continue to broaden coverage for high-complexity tests, while the Brazilian Multipurpose Reactor (RMB) in Iperó promises a resilient isotope supply chain. Competitive rivalry intensifies as hospital networks consolidate and outpatient imaging centers gain share, yet a shortage of nuclear-medicine specialists and high acquisition costs temper near-term growth momentum. Infrastructure modernization programs, public-private cyclotron partnerships, and e-labeling reforms by ANVISA are opening streamlined pathways for technology deployment.

Key Report Takeaways

By product, equipment led with 64.67% revenue share of the Brazil nuclear imaging market in 2024, Radioisotopes are projected to post the fastest 7.04% CAGR through 2030.

By application, cardiology accounted for 63.89% of the Brazil nuclear imaging market share in 2024, Neurology imaging is forecast to grow at a 7.19% CAGR to 2030.

By end user, hospitals held 72.67% of the Brazil nuclear imaging market size in 2024, Diagnostic imaging centers are expected to advance at a 7.00% CAGR through 2030.

Segment Analysis

By Product: Equipment Dominance Drives Infrastructure Expansion

Brazil nuclear imaging market size for equipment reached USD 156.1 billion in 2024, representing 64.67% of total value. Hybrid PET/CT and SPECT/CT platforms account for the bulk of purchases as hospitals retire aging Anger cameras. Full-ring CZT SPECT systems improve coronary artery visualization and trim scan times, supporting higher patient throughput. The Brazil nuclear imaging market size for radioisotopes is forecast to rise at a 7.04% CAGR, propelled by RMB-enabled molybdenum-99 output and cyclotron expansion in underserved states. SPECT isotopes such as technetium-99m still represent 80% of procedure volume, yet PET tracers like 18F and 68Ga gain momentum in oncology and cardiology.

Financial hurdles persist. Capital cost per digital PET/CT exceeds USD 2 million, and rural clinics rely on leasing or volume-based vendor arrangements. GE HealthCare’s MINItrace Magni lowers tracer logistics costs, positioning mid-tier hospitals to upgrade. RMB production is slated to reduce 99Mo import costs by 40% once fully operational, enhancing isotope affordability. Long-term demand for PET/MRI remains niche due to USD 7 million price tags and high service requirements, yet early adopters cite diagnostic differentiation in neuro-oncology and congenital heart disease imaging.

Brazil Nuclear Imaging Market: Market Share by Product
Image © Mordor Intelligence. Reuse requires attribution under CC BY 4.0.
Get Detailed Market Forecasts at the Most Granular Levels
Download PDF

By Application: Cardiology Leadership Faces Neurological Growth

Cardiology commanded a 63.89% share of the Brazil nuclear imaging market in 2024. Myocardial perfusion scintigraphy remains the clinical workhorse, supported by Brazilian Society of Cardiology guidelines affirming cost-effectiveness relative to invasive angiography . CZT detectors have cut scan times by 70%, allowing urban centers to clear backlogs and boost throughput. Neurology contributes the smallest revenue today but posts the highest 7.19% CAGR, lifted by Alzheimer’s and Parkinson’s disease prevalence and expanded access to amyloid-PET probes.

Oncology also accelerates on regulatory clearances of PSMA agents and alpha-emitter therapeutics. Thyroid applications remain stable, with 93.3% cure rates for Graves’ disease using radioiodine confirming therapeutic utility. The Brazil nuclear imaging market share for neurology is projected to double by 2030 as PET/MRI capacity broadens. Cardiac centers in São Paulo now integrate reserve-flow quantification, while regional hospitals in the Northeast focus on essential gated-SPECT protocols due to budget constraints.

By End User: Hospital Dominance Shifts Toward Specialized Centers

Hospitals represented 72.67% of Brazil nuclear imaging market size in 2024, reflecting their infrastructure advantage and critical-care alignment. Private hospital groups such as DASA and Rede D’Or are enlarging bed counts and investing in hybrid scanners to support cardiology and oncology service lines. Diagnostic imaging centers, however, register the quickest 7.00% CAGR as outpatient demand for shorter wait times rises. These stand-alone facilities increasingly sign reagent-supply contracts with isotope producers and adopt point-of-care PET radiopharmacy units.

Academic institutes and research hospitals collaborate with IPEN to trial theranostic protocols and train fellows, supplying a modest but strategic demand segment. Hospital-network consolidation continues: DASA’s proposed merger with Amil would create a 4,500-bed platform capable of bulk-buying scanners and negotiating favorable service contracts. Outpatient chains counter by emphasizing flexible scheduling, AI-assisted workflow, and Same-Day results, all of which strengthen their value proposition.

Brazil Nuclear Imaging Market: Market Share by End User
Image © Mordor Intelligence. Reuse requires attribution under CC BY 4.0.
Get Detailed Market Forecasts at the Most Granular Levels
Download PDF

Geography Analysis

The Brazil nuclear imaging market shows strong regional concentration. São Paulo and Rio de Janeiro account for more than 55% of installed scanners and host the RMB and IPEN complexes, anchoring isotope logistics. Physician density in the South reaches 10.26 per 1,000 inhabitants, enabling higher per-capita procedure rates. Conversely, the North and parts of the Northeast face scant infrastructure and specialist shortages, limiting exam availability. The IAEA-donated SPECT camera in Niterói illustrates targeted interventions to bridge capability gaps.

New cyclotron ventures aim to supply short-lived PET tracers locally, cutting transport losses and stimulating regional demand. Government initiatives such as Programa Mais Médicos bolster general physician presence but stop short of nuclear specialization. State fiscal capacity shapes purchasing cycles: wealthier states upgrade to digital PET/CT on five-year timelines, while interior clinics depend on refurbished systems. Tele-nuclear medicine pilots link remote sites to metropolitan readers, partially offsetting specialist scarcity.

Urban networks leverage AI and cloud-PACS to centralize image interpretation, widening service radius without duplicating staff. Yet isotope supply remains vulnerable to logistics disruptions in Amazonian regions, where river transport causes delivery delays. RMB’s ramp-up, complemented by INB’s uranium exports, is expected to stabilize nationwide isotope availability by 2028. The Ministry of Health’s 800-bed digital hospital in São Paulo underscores public-sector commitment to smart healthcare infrastructure and may serve as a blueprint for other state capitals.

Competitive Landscape

The Brazil nuclear imaging market is moderately consolidated. Top equipment vendors—GE HealthCare, Siemens Healthineers, Philips, Canon Medical, and United Imaging—compete on detector innovation and workflow automation, while national service giants DASA and Fleury scale through acquisitions and joint ventures. DASA recorded record EBITDA in 2025 and seeks platform growth via merger with Amil, potentially expanding bargaining power over scanner procurement. Fleury favors partnerships to mitigate capital costs and taps regional niches.

Cyclotron operators such as Cyclobrás and RPH pursue vertical integration from isotope production to tracer distribution. The RMB project introduces state-controlled isotope capacity, shifting buyer leverage from importers to domestic suppliers. Regulatory reforms on e-labeling and software oversight require robust compliance, giving larger operators an administrative edge. Niche entrants target outpatient cardiac PET and neurological PET/MRI, differentiating on subspecialty reporting and quicker turnaround. Market entry barriers persist in rural zones due to physician scarcity and licensing complexity, yet public-private collaborations could unlock white-space opportunities in the North and Northeast.

Brazil Nuclear Imaging Industry Leaders

  1. GE Healthcare

  2. Grupo RPH

  3. Siemens Healthineers AG

  4. Canon Inc. (Canon Medical Systems Corporation)

  5. Koninklijke Philips N.V.

  6. *Disclaimer: Major Players sorted in no particular order
Picture23.png
Image © Mordor Intelligence. Reuse requires attribution under CC BY 4.0.
Need More Details on Market Players and Competitors?
Download PDF

Recent Industry Developments

  • March 2025: Telix Pharmaceuticals received Brazilian approval for a PSMA imaging agent, expanding precision oncology diagnostics
  • March 2025: INB secured a contract to export 275,000 kg of uranium concentrate, underscoring Brazil’s upstream nuclear capability

Table of Contents for Brazil Nuclear Imaging Industry Report

1. Introduction

  • 1.1 Study Assumptions & Market Definition
  • 1.2 Scope of the Study

2. Research Methodology

3. Executive Summary

4. Market Landscape

  • 4.1 Market Overview
  • 4.2 Market Drivers
    • 4.2.1 Escalating cancer & CVD incidence
    • 4.2.2 Expansion of private health-insurance coverage
    • 4.2.3 Federal investments in domestically produced Mo-99
    • 4.2.4 Rapid adoption of digital & hybrid PET/CT platforms
    • 4.2.5 New multipurpose research reactor (RMB) enabling isotope security
    • 4.2.6 Public-private cyclotron partnerships in underserved regions
  • 4.3 Market Restraints
    • 4.3.1 High acquisition & upkeep cost of imaging systems
    • 4.3.2 Complex CNEN / ANVISA licensing procedures
    • 4.3.3 Workforce shortage of certified nuclear-medicine specialists
    • 4.3.4 Periodic supply disruptions of I-131 & Tc-99m isotopes
  • 4.4 Value / Supply-Chain Analysis
  • 4.5 Regulatory Landscape
  • 4.6 Technological Outlook
  • 4.7 Porter’s Five Forces
    • 4.7.1 Threat of New Entrants
    • 4.7.2 Bargaining Power of Suppliers
    • 4.7.3 Bargaining Power of Buyers
    • 4.7.4 Threat of Substitutes
    • 4.7.5 Competitive Rivalry

5. Market Size & Growth Forecasts (Value, BRL million)

  • 5.1 By Product (Value)
    • 5.1.1 Equipment
    • 5.1.1.1 PET/CT Scanners
    • 5.1.1.2 SPECT/CT Scanners
    • 5.1.1.3 PET/MRI Scanners
    • 5.1.2 Radioisotopes
    • 5.1.2.1 SPECT Radioisotopes
    • 5.1.2.1.1 Technetium-99m (Tc-99m)
    • 5.1.2.1.2 Thallium-201 (Tl-201)
    • 5.1.2.1.3 Gallium-67 (Ga-67)
    • 5.1.2.1.4 Iodine-123 (I-123)
    • 5.1.2.1.5 Other SPECT Isotopes
    • 5.1.2.2 PET Radioisotopes
    • 5.1.2.2.1 Fluorine-18 (F-18)
    • 5.1.2.2.2 Rubidium-82 (Rb-82)
    • 5.1.2.2.3 Other PET Isotopes
  • 5.2 By Application (Value)
    • 5.2.1 Cardiology
    • 5.2.2 Neurology
    • 5.2.3 Thyroid
    • 5.2.4 Oncology
    • 5.2.5 Other PET Applications
  • 5.3 By End User (Value)
    • 5.3.1 Hospitals
    • 5.3.2 Diagnostic Imaging Centres
    • 5.3.3 Academic & Research Institutes

6. Competitive Landscape

  • 6.1 Market Concentration
  • 6.2 Market Share Analysis
  • 6.3 Company Profiles (includes Global level Overview, Market level overview, Core Segments, Financials as available, Strategic Information, Market Rank/Share, Products & Services, Recent Developments)
    • 6.3.1 GE HealthCare Technologies Inc.
    • 6.3.2 Siemens Healthineers AG
    • 6.3.3 Koninklijke Philips N.V.
    • 6.3.4 Canon Medical Systems Corp.
    • 6.3.5 United Imaging Healthcare Co., Ltd.
    • 6.3.6 Ion Beam Applications SA (IBA)
    • 6.3.7 Curium Pharma SA
    • 6.3.8 Bracco Imaging S.p.A.
    • 6.3.9 Cardinal Health Inc.
    • 6.3.10 Eckert & Ziegler AG
    • 6.3.11 Cyclobrás Tecnologias e Serviços de Medicina Nuclear Ltda.
    • 6.3.12 Diagnósticos da América S.A. (DASA)
    • 6.3.13 Grupo Fleury S.A.
    • 6.3.14 RPH Rede Brasileira de Farmácias de Radiofármacos

7. Market Opportunities & Future Outlook

  • 7.1 White-space & Unmet-Need Assessment
You Can Purchase Parts Of This Report. Check Out Prices For Specific Sections
Get Price Break-up Now

Brazil Nuclear Imaging Market Report Scope

As per the scope of the report, nuclear medicine imaging procedures are non-invasive, with the exception of intravenous injections, and are usually painless medical tests that help physicians diagnose and evaluate medical conditions. These imaging scans use radioactive materials called radiopharmaceuticals or radiotracers. These radiopharmaceuticals are used in diagnosis and therapeutics. They are small substances that contain a radioactive substance that is used in the treatment of cancer, cardiac and neurological disorders. Brazil Nuclear Imaging Market is segmented by Product (Equipment, and Diagnostic Radioisotope (SPECT Radioisotopes, and PET Radioisotopes), Application (SPECT Application (Cardiology, Neurology, Thyroid, and Other SPECT Applications), and PET Application (Oncology, Cardiology, Neurology, and Other PET Applications). The report offers the value (in USD million) for the above segments.

By Product (Value)
Equipment PET/CT Scanners
SPECT/CT Scanners
PET/MRI Scanners
Radioisotopes SPECT Radioisotopes Technetium-99m (Tc-99m)
Thallium-201 (Tl-201)
Gallium-67 (Ga-67)
Iodine-123 (I-123)
Other SPECT Isotopes
PET Radioisotopes Fluorine-18 (F-18)
Rubidium-82 (Rb-82)
Other PET Isotopes
By Application (Value)
Cardiology
Neurology
Thyroid
Oncology
Other PET Applications
By End User (Value)
Hospitals
Diagnostic Imaging Centres
Academic & Research Institutes
By Product (Value) Equipment PET/CT Scanners
SPECT/CT Scanners
PET/MRI Scanners
Radioisotopes SPECT Radioisotopes Technetium-99m (Tc-99m)
Thallium-201 (Tl-201)
Gallium-67 (Ga-67)
Iodine-123 (I-123)
Other SPECT Isotopes
PET Radioisotopes Fluorine-18 (F-18)
Rubidium-82 (Rb-82)
Other PET Isotopes
By Application (Value) Cardiology
Neurology
Thyroid
Oncology
Other PET Applications
By End User (Value) Hospitals
Diagnostic Imaging Centres
Academic & Research Institutes
Need A Different Region or Segment?
Customize Now

Key Questions Answered in the Report

How large is the Brazil nuclear imaging market in 2025?

The Brazil nuclear imaging market size is USD 241.27 billion in 2025 and is projected to climb to USD 335.14 billion by 2030.

Which product category leads sales?

Equipment including PET/CT, SPECT/CT, and the first PET/MRI units accounts for 64.67% of 2024 revenue.

What application generates most demand?

Cardiology holds 63.89% of 2024 value because myocardial perfusion imaging is widely adopted for coronary artery disease assessment.

Where are most scanners located?

São Paulo and Rio de Janeiro concentrate over half of the nation's PET and SPECT installations, reflecting higher physician density and private investment.

Who are the key service providers?

DASA, Fleury, and Rede D'Or top the list, with DASA planning a 4,500-bed network that will deepen its imaging footprint.

What limits faster growth?

High equipment costs and a shortage of just 499 certified nuclear-medicine specialists nationwide constrain service expansion, especially in the North and Northeast.

Page last updated on:

Brazil Nuclear Imaging Report Snapshots